TrueTicker

NIFTY 500 › Fast Moving Consumer Goods

Fast Moving Consumer Goods · NIFTY 500

Zydus Wellness Ltd.

ZYDUSWELL on NSE · 19 Nov 2026

NIFTY 500

455.85 ▼ -0.16 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Guidance tracker

What ZYDUSWELL guided, and what came next

FiledWhat the filing saysNext results: profit YoYRevenueMove on the day
07 Nov 2026Zydus Wellness filed the transcript of its Q2 FY2027 earnings conference call held on November 3, 2026. Management (CEO Tarun Arora) said consolidated net sales for Q2 FY27 were INR 11,227 million, up 74.6% year-on-year, and EBITDA was INR 855 million, up 271.7%. For the half year ended September 30, 2026, net... NSE copy No results filed since
22 May 2026Zydus Wellness filed the transcript of its Q4 FY2026 earnings conference call held on May 18, 2026. Management said Q4 net sales grew 62.1% and FY26 net sales grew 46.4%, with international (including Comfort Click) like-to-like growth of 31.4% in Q4 and 29.5% for FY26, and domestic growth of 1.7% in Q4 and 2.4%... NSE copy -7.0 %+66.9 %-3.6 %
09 Feb 2026Zydus Wellness filed the transcript of its Q3 FY2026 earnings conference call held on February 3, 2026. Management said consolidated net sales grew 113.7% year-on-year in Q3 FY26, with Food & Nutrition up 134% and Personal Care down 1.4%; consolidated EBITDA was INR610 million, with EBITDA margin of 6.3% versus... NSE copy --+2.7 %
05 Aug 2025Zydus Wellness filed the transcript of its Q1 FY2026 earnings conference call held on July 30, 2025. Management said consolidated net sales grew 2.2% to Rs. 8,577 million; excluding seasonal brands, growth was double-digit, and organic volume and value growth was near flattish including seasonal brands. Management... NSE copy -352.6 %+32.0 %-4.1 %
23 May 2025Zydus Wellness filed the transcript of its Q4 FY2025 earnings conference call held on May 19, 2025, under Regulations 30 and 46(2)(oa)(iii) of the SEBI Listing Regulations. Management said Q4 consolidated net sales grew 17% to INR 9,106 million, with volume growth of 13%; FY2025 net sales grew 16.2% to INR 26,912... NSE copy -13.4 %+2.4 %-1.2 %
10 Feb 2025Zydus Wellness filed the transcript of its Q3 FY2025 earnings conference call held on February 4, 2025, under Regulations 30 and 46(2)(oa)(iii) of the SEBI LODR Regulations. Management said consolidated net sales grew 12.7% to INR 4,508 million, with volume growth of 4.8% year-on-year, and EBITDA grew 16.5%... NSE copy -13.4 %+2.4 %-1.2 %

Filings tagged as guidance, newest first (6 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.

Governance

Management, auditors, ratings and legal matters

FiledKindWhat the filing says
02 Sep 2026Management changeZydus Wellness filed the transcript of its 32nd Annual General Meeting, held virtually on August 4, 2026 (10:00 to 10:48 A.M. IST). Chairman Dr. Sharvil P. Patel said revenue from operations rose 46.2% to Rs. 36,610 million in FY26 and EBITDA grew 34.2% to Rs. 5,097 million, with seasonal brands hit by delayed... NSE copy
19 Aug 2026Credit ratingZydus Wellness Limited intimated that CARE Ratings Limited has assigned a credit rating to long-term bank facilities of Zydus Wellness Products Limited, a wholly owned material subsidiary. Rated long-term bank facilities amount: ₹12.00 crore; rating: CARE AA+; Stable (assigned). The intimation was received by email... NSE copy
10 Nov 2025Legal or regulatoryZydus Wellness filed the transcript of its Q2 FY2026 earnings conference call held on November 5, 2025. Management said consolidated net sales grew 31% for the quarter and 12.8% for H1 FY26, driven by newly acquired entities, offsetting seasonal product pressure; consolidated EBITDA was INR230 million, up 17.3%... NSE copy
19 May 2025Legal or regulatoryBoard of Zydus Wellness Limited recommended a final dividend of ₹6.00 per equity share (60% on ₹10 face value), subject to members' approval at the AGM on July 30, 2025; record date is Friday, July 11, 2025, and payment on or after August 4, 2025. Board proposed sub-division of equity shares: 1 equity share of ₹10... NSE copy

Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (4 in all). A list of what was filed, not a judgement of the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in